(NYSE: TFX) Teleflex's forecast annual revenue growth rate of -0.83% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Teleflex's revenue in 2026 is $2,600,599,000.On average, 16 Wall Street analysts forecast TFX's revenue for 2026 to be $97,880,237,070, with the lowest TFX revenue forecast at $94,575,190,104, and the highest TFX revenue forecast at $102,032,731,976. On average, 16 Wall Street analysts forecast TFX's revenue for 2027 to be $102,583,573,137, with the lowest TFX revenue forecast at $97,964,981,864, and the highest TFX revenue forecast at $107,244,536,807.
In 2028, TFX is forecast to generate $107,541,143,586 in revenue, with the lowest revenue forecast at $101,863,242,388 and the highest revenue forecast at $112,922,438,005.